Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Molecular Therapy Oncolytics|January 1, 2020
Syncytia Formation in Oncolytic VirotherapyChase Burton, Eric BarteeOncolytic Virotherapy|December 19, 2019
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma VirusChase Burton, Mee Y Bartee, Eric BarteeOncolytic Virotherapy|December 13, 2018
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiformeChase Burton, Arabinda Das, Daniel McDonald, et al.Oncolytic Virotherapy|March 6, 2018
Potential of oncolytic viruses in the treatment of multiple myelomaEric BarteeCytokine|July 31, 2009
Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-betaEric Bartee, Grant McFaddenExperimental Hematology & Oncology|May 27, 2017
In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockadeEric Bartee, Zihai LiCytokine|May 23, 2013
Cytokine synergy: an underappreciated contributor to innate anti-viral immunityEric Bartee, Grant McFaddenJournal for Immunotherapy of Cancer|April 13, 2022
The use of oncolytic virotherapy in the neoadjuvant settingRaquela J Thomas, Eric BarteeMolecular Therapy Oncolytics|December 18, 2020
Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic VirotherapyErica B Flores, Eric BarteePlos Pathogens|January 24, 2007
Quantitative membrane proteomics reveals new cellular targets of viral immune modulatorsEric Bartee, Ashley McCormack, Klaus FrühPageof 6